Treatment | Total n | Cleavage (%) | Blastocyst (%) | Viable cells in blastocysts % | Total no. of nuclei (means ± S.D.) |
---|---|---|---|---|---|
IVF | |||||
 Control (DO-GC) | 100 | 73 (73 ± 3.4)a | 15 (15 ± 1.2)a | 82 ± 3a | 50 ± 0.6a |
 Vitrification | 210 | 142 (68 ± 2)a | 30 (14 ± 1.8)a | 70 ± 5b | 46 ± 3a |
ICSI | |||||
 Control (DO-GC) | 74 | 33 (45 ± 2)b | 9 (12 ± 0.3)a | 100c | 44 ± 0.9b |
 Vitrification | 113 | 45 (40 ± 9)b | 10 (9 ± 0.2)b | 42 ± 5d | 41 ± 2b |
PICSI | |||||
 Control (DO-GC) | 60 | 38 (63 ± 2)a | 18 (30 ± 1.5)c | 100c | 50 ± 2.5a |
 Vitrification | 158 | 99 (63 ± 3.5)a | 39 (25 ± 3)c | 100c | 54 ± 5a |